1. Sanjib Sinha, AB Taly. Wilson's Disease. Part 18 Ch.7 In: YP Munjal, SK Sharma, AK Agarwal, P Gupta et al, editors. API Textbook of Medicine Volume 2, 10th ed. Jaypee Brothers Medical Publication, 2015; p.1716-1721
2. George J. Brewer. wilson's Disease. Ch.429 In: Kasper DL ,Hauser SL, Jameson JL, editors. Harrison's Principles of Internal Medicine, 19th ed. New York: McGraw Hill, 2016; p. 2519-2521
3. Roberts EA, Schilsky ML. Diagnosis and Treatment of Wilson Disease: an update hepatomegaly. 2008: 2089-2111
4. Fahn S, Jankovic J, Hallet M. Principles and practice of movement disorder. 2nd ed. New York: Elsevier Saunder;2011. Wilson disease; pp. 507-12
5. Pagon RA, Adam MP, Ardinger HH et al editors. GeneReviews®[Internet] Seattle (WA): university of Washington, Seattle; 1993-2017. 1999 oct 22[updated 2016 July 29]
6. Rukunuzzaman M. Wilson disease in Bangladeshi children: Analysis of 100 cases. Pediatr Gastrornterol Hepatol Nutr. 2015; 18:121-7
7. Kim TJ, Kim IO, Kim WS et al. MR imaging of brain in Wilson disease of childhood: findings before and after treatment with clinical correlation. AJNR Am J Neuro radiol. 2006;27:1373-8
8. Lorincz MT. Neurologic Wilson's disease. Ann N Y Acad Sci 2010;1184:173–187
9. Taly AB, Meenakshi-Sundaram S, Sinha S, Swamy HS, Arunodaya GR. Wilson disease: description of 282 patients evaluated over 3 decades. Medicine (Baltimore) 2007;86(2):112–121
10. Brewer GJ, Yuzbasiyan-Gurkan V. Wilson disease. Medicine (Baltimore) 1992;71(3): 139–164
11. Wiebers DO, Hollenhorst RW, Goldstein NP. The ophthalmologic manifestations of Wilson's disease. Mayo Clin Proc 1977;52 (7):409–416
12. Shivakumar R, Thomas SV. Teaching NeuroImages: face of giant panda and her cub: MRI correlates of Wilson disease. Neurology.2009;72:e50
13. Hoogenraad TU. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice. Brain Dev 2006;28(3):141–146.
14. Brewer GJ, Askari F, Lorincz MT, et al. Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease. Arch Neurol 2006;63 (4):521–527.